Operating Lease, Right-of-Use Asset of Intra-Cellular Therapies, Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $13,428,000, a 3.9% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $13,428,000 +$500,000 +3.9% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $14,011,000 +$647,000 +4.8% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $14,507,000 +$720,000 +5.2% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $12,481,000 -$1,718,000 -12% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $12,928,000 -$1,896,000 -13% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $13,364,000 -$6,709,000 -33% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $13,787,000 -$6,690,000 -33% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $14,199,000 -$3,768,000 -21% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $14,824,000 -$5,940,000 -29% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $20,073,000 -$1,637,677 -7.5% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $20,477,000 -$2,069,333 -9.2% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $17,967,000 -$5,463,703 -23% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $20,764,000 -$3,560,762 -15% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $21,710,677 -$2,581,490 -11% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $22,546,333 +$2,275,658 +11% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $23,430,703 +$5,379,557 +30% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $24,324,762 +$6,072,688 +33% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $24,292,167 +$5,751,749 +31% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $20,270,675 +$1,448,193 +7.7% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $18,051,146 -$2,053,134 -10% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $18,252,074 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $18,540,418 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $18,822,482 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $20,104,280 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.